
|
Jozsef Repasi.
Managing Director
Ubichem Research Ltd
|
| Jozsef Repasi is Managing Director at Ubichem Research Ltd. and director of Ubichem Plc. He has held his managing director position since the creation of the company in 1996. Répási earned a Masters Degree in Science, specializing in |
full profile »
|
 |
Rod Mackenzie
Senior Vice President
Head of PharmaTherapeutics Research and Development Pfizer, Inc
|
| Rod MacKenzie is Senior Vice President, Head of Worldwide Research for the PharmaTherapeutics division of Pfizer. He leads the organisation responsible for bringing forward the next generation of positive Proof of Concept molecules to... |
| |
full profile »
|
 |
Ted Torphy, Ph.D.
Vice President & Head, External Innovation
Research Capabilities Johnson & Johnson Pharmaceuticals
|
Ted Torphy is now Vice President & Head, External Innovation
Research Capabilities but was recently Chief Scientific Officer and Head of External Research & Early Development (eRED) for Johnson & Johnson’s Pharmaceuticals Group... |
| |
full profile »
|
 |
Kalpana M. Merchant, Ph.D.
Chief Scientific Officer for Translational Science
Eli Lilly and Company
|
| Dr. Merchant is currently the Chief Scientific Officer for Translational Science in Lilly Research Laboratories at Eli Lilly and Company. Her group is responsible for providing scientific data that connect drug targets to disease state... |
| |
full profile »
|

|
Dr. Tony Owen
Worldwide Director of Marketing
Agilent Technologies
|
| Dr. Tony Owen is the worldwide director of marketing for chromatography and informatics software products, a part of the Agilent Technologies Life Sciences Group (LSG), and is based in Waldbronn, Germany... |
full profile »
|
 |
Michael Dorato, Ph.D., D.A.B.T.
Vice President, Discovery Services
Covance, Discovery & Translational Services
|
| Thirty years experience in the pharmaceutical industry, primarily in Lead optimisation and GLP toxicology, drug development decisions, regulatory interactions. I have taken discovery compounds in to clinical trials and final registration. |
full profile »
|

|
Eric D Perakslis PhD
Vice President of R&D Information Technology
Johnson & Johnson Pharmaceuticals R&D
|
| Eric is currently Vice President of R&D Information Technology at Johnson & Johnson Pharmaceuticals R&D and is a member of the Corporate Office of Science and Technology. Eric is in his thirteenth year at J&J and has held the posts of... |
full profile »
|
 |
John Burkhardt
Global Head of Preclinical Safety
Abbott Laboratories
|
| John Burkhardt is Global Head of Preclinical Safety at Abbott Laboratories, where he is responsible for all aspects of Toxicology, Pathology, Comparative Medicine, and related fields... |
| |
full profile »
|
| |
|
|
|
 |
|
Keith Russell PhD., MBB
Global R&D Design & Innovation Continuous Improvement Leader AstraZeneca Pharmaceuticals
|
| Keith Russell obtained his PhD from the University of Cambridge, UK with Dr. A. B. Holmes in 1984 in the area of synthetic organic chemistry. He was then awarded a NATO post-doctoral fellowship to work with Professor L. A. Paquette.. |
| |
full profile »
|
 |
|
Martin D. Leach, Ph.D.
Executive Director, MRL IT for Discovery & Preclinical Sciences
|
| At Merck & Co., I lead IT for Discovery & Preclinical Sciences (DPS) working with leadership in DPS research groups to develop and manage a portfolio of research applications, systems and high performance computing infrastructure to... |
| |
full profile »
|
 |
|
Joseph Donahue
SVP, Global Sales
Thomson Reuters
|
| Joe Donahue is Vice President, Commercial Operations Life Sciences at Thomson Reuters Healthcare & Science. Mr. Donahue has more than fifteen years of executive level entrepreneurial and Board experience in global life sciences |
| |
full profile »
|
 |
|
Jonathan Koch
Vice President and General Manager
Discovery and Translational Services (DTS)
|
| Jonathan Koch is currently Vice President and General Manager of Covance’s Discovery and Translational Services (DTS) organization, and General Manager of the Company’s diverse Greenfield, Indiana... |
| |
full profile »
|

|
Marc K. Hellerstein, M.D., Ph.D
Co-Founder, Chairman,
The Scientific Advisory Board
|
| Dr. Hellerstein joined the faculty of the UC Berkeley, in 1987 after completing medical training at Yale Medical School with a fellowship in endocrinology at New England Medical Center and a PhD in Nutritional Biochemistry from Massachusetts... |
full profile »
|

|
Dennis X Murray
PG Site Head Nutley NJ USA,
Global Head Drug Safety and Pharma Partnering Info. & Mgt
|
| Dennis joined Roche in 2000 after leaving Novartis Pharmaceuticals where he had various positions including Head of Collaboration Systems and Business Information Officer for Global Regulatory and Pharmacovigilance. He |
full profile »
|

|
Stevan W Djuric, PhD
Senior Director Abbott Laboratories
Illinois, USA. |
| Dr Stevan Djuric is responsible for the Medicinal Chemistry Technology and Structural Chemistry groups at Abbott Laboratories. Their current efforts are focused on new initiatives in the areas of high throughput synthesis and... |
| |
|
full profile » |
|